Choriocarcinoma

10 registered clinical trials studyying Choriocarcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Molecular Epidemiology of Pediatric Germ Cell Tumors NCT05564026	Children's Oncology Group	—
Recruiting	A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT NCT04684368	Children's Oncology Group	Phase 2
Active Not Recruiting	Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neop NCT04562558	xiang yang	N/A
Terminated	Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) NCT02664961	Tracon Pharmaceuticals Inc.	Phase 2
Active Not Recruiting	Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treat NCT02375204	Alliance for Clinical Trials in Oncology	Phase 3
Completed	TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma NCT02396511	Tracon Pharmaceuticals Inc.	Phase 2
Completed	Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia NCT01535053	GOG Foundation	Phase 3
Unknown	Clinical Database and Biobank of Patients With Gynecologic Neoplasms NCT01267851	Huazhong University of Science and Technology	—
Unknown	Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma NCT00294177	National Taiwan University Hospital	—
Completed	A Trial for Patients With Gestational Trophoblastic Disease NCT00190918	Eli Lilly and Company	Phase 2